| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 60 |
| 1 | ASPIRIN | 33 |
| 2 | ASPIRIN 325 MG | 30 |
| 3 | ASPIRIN 81 MG | 30 |
| 4 | DEXAMETHASONE | 30 |
| 5 | DEXAMETHASONE 1.5 MG | 30 |
| 6 | RIVAROXABAN | 28 |
| 7 | ACETAMINOPHEN | 26 |
| 8 | ACETAMINOPHEN 500MG | 23 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIDESAMTINIB | 1 | 1.0000 |
| 1 | HUMAN FIBRINOGEN, HUMAN THROMBIN | 1 | 0.0172 |
| 2 | ANDEXANET ALFA | 11 | 0.0155 |
| 3 | PRAZIQUANTEL | 4 | 0.0132 |
| 4 | HYDROCORTISONE VALERATE | 6 | 0.0096 |
| 5 | TRIFAROTENE | 1 | 0.0055 |
| 6 | CLEVIDIPINE | 2 | 0.0054 |
| 7 | TENECTEPLASE | 8 | 0.0050 |
| 8 | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 1 | 0.0040 |
| 9 | IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA | 1 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 88 |
| 1 | Corticosteroid [EPC] | 62 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 33 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 23 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 21 |
| 6 | Alkylating Drug [EPC] | 17 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 15 |
| 9 | Proton Pump Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Anthelmintic [EPC] | 4 | 0.0014 |
| 2 | Amyloid Beta-directed Antibody [EPC] | 5 | 0.0013 |
| 3 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 4 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 6 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 7 | Antimalarial [EPC] | 5 | 0.0005 |
| 8 | Antiprotozoal [EPC] | 5 | 0.0005 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |